Skip to content
No results
  • Home page
  • Disclaimer
  • Feedback
  • Contact
Pharmavibes

medicines-medical devices-regulatory affairs

  • Disclaimer
  • Feedback
  • Contact
  • Home
Pharmavibes

medicines-medical devices-regulatory affairs

  • CMDh updates

CMDh and other EU updates-September 2026

EU flag

Report from the CMDh meeting held on 15-17 September 2026 The reports from the CMDh meetings (also called press releases) reflect highlights/important outcomes of each meeting and are usually published in the week following the CMDh meeting. The reports therefore…

Read MoreCMDh and other EU updates-September 2026
  • 23 September 2026
  • News in brief

International regulatory news in brief

Image with the word 'Regulations'

This post covers international regulatory news in brief. It is updated on an ad hoc basis. For ease of navigation, a tab has been added for each region/topic (below). Each tab includes the date for most recent update under that particular tab.…

Read MoreInternational regulatory news in brief
  • 23 September 2026
  • Clinical trials, MHRA (UK), Pilot program

MHRA guidance on a Phase 1, 14-day pilot programme for clinical trials

Last updated: 22 September 2026 To see updates, click on the ‘+’ sign below. The MHRA has today published guidance on a Phase 1, 14-day pilot programme for clinical trials. Below is an attempt to present the information in a…

Read MoreMHRA guidance on a Phase 1, 14-day pilot programme for clinical trials
  • 22 September 2026
  • European Commission, European Union, Health Technology Assessment, New legislation

The Regulation (EU) 2021/2282 on Health Technology Assessment

Last updated: 18 September 2026 This post is an attempt to provide basic information on Health Technology, its assessment and the new Regulation (EU) 2021 Click on the ‘+’ sign next to each heading to access the information under each…

Read MoreThe Regulation (EU) 2021/2282 on Health Technology Assessment
  • 18 September 2026
  • MHRA (UK), National assessment procedure

MHRA Guidance – National assessment procedure for medicines

Last updated: 17 September 2026 To view updates, click on the ‘+’ sign below The MHRA offers a national assessment procedure for UK-wide marketing authorisation (MA) applications. This new guidance for applicants is effective for applications received after 3rd April…

Read MoreMHRA Guidance – National assessment procedure for medicines
  • 17 September 2026
  • Clinical trials, Pilot program, US FDA

US FDA launches Expedited IND pilot

The U.S. FDA today announced the final design of the Expedited Investigational New Drug (IND) Pilot. What does the pilot aim to achieve? Driven by the President’s directive, the pilot seeks to accelerate the time it takes from identifying a drug…

Read MoreUS FDA launches Expedited IND pilot
  • 15 September 2026
  • European Medicines Agency, Medicines Licensing, Pilot project

EMA pre-submission interactions (PSI) model pilot

The EMA is inviting marketing authorisation applicants to take part in an 18-month pre-submission interactions (PSI) model pilot.  When did EMA launch the pilot? The pilot was launched in September 2026 The pre-submission interactions (PSI) model pilot introduces shared ownership and early dialogue…

Read MoreEMA pre-submission interactions (PSI) model pilot
  • 13 September 2026
  • Medical Device Coordination Group

Medical Device Coordination Group (MDCG) updates – July – September 2026

Date Guidance No About the guidance Sept 2026 MDCG 2020-16 rev.5 Guidance on Classification Rules for in vitro Diagnostic Medical Devices under Regulation (EU) 2017/746 (September 2026) The changes are as follows:Rule 7 : Clarification of the rationale and revision…

Read MoreMedical Device Coordination Group (MDCG) updates – July – September 2026
  • 9 September 2026
  • International Recognition Procedure (IRP), Medicines Licensing, MHRA (UK)

MHRA guidance on the International Recognition Procedure (IRP)

Last updated: 3 September 2026 The UK MHRA has published guidance on the International Recognition Procedure which became operational on 1 January 2024. This post is an attempt to present the information in a Q&A format. The information is by…

Read MoreMHRA guidance on the International Recognition Procedure (IRP)
  • 3 September 2026
  • Guidance for industry, US FDA

US FDA guidance for industry July – Sept 2026

You can listen to available guidance podcasts at this link. Date Title of guidance and link to document Type and levelof guidance About the guidance 31 Aug 2026 Pharmacokinetics in Patients with Impaired Hepatic Function: Study Design, Data Analysis, and…

Read MoreUS FDA guidance for industry July – Sept 2026
  • 31 August 2026
  • CMDh updates

CMDh and other EU updates August 2026

EU flag

Last updated: 23 September 2026 To view updates, click on the ‘+’ sign below. Updated PLM Portal eAF Release notes now available An updated version of the PLM Portal eAF Release notes reflecting bug fixes and updates to web eAF…

Read MoreCMDh and other EU updates August 2026
  • 23 August 2026
  • Clinical trials, MHRA (UK), New legislation

New UK clinical trials regulations

Last updated: 20 August 2026 Below is an attempt to provide information on the new clinical trials regulations. The information is by no means complete or exhaustive. Please use this post as a starting point and take the time to…

Read MoreNew UK clinical trials regulations
  • 20 August 2026
Next
No results

Copyright © 2026 Pharmavibes